A Phase 2, Randomized Clinical Study of Intravenous or Intratumoral Administration of V937 in Combination with Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants with Advanced/Metastatic Melanoma
- Haydon, Andrew (Primary Chief Investigator (PCI))
- Hawkins, Cheryl-Ann (Project Manager)
- Khattak, Adnan (Chief Investigator (CI))
Project: Research